Search results
Results from the WOW.Com Content Network
Topiramate weight loss is shown in studies, but it’s not approved as a weight loss drug on its own. It’s designed as an anticonvulsant for epilepsy and migraine prevention and prescribed off ...
6. Phentermine-topiramate. Dr. Teixeira explains that phentermine and topiramate are two extended release capsules that work together to help with weight loss by decreasing appetite ...
3. Undergoing Cancer Treatment. Many people with cancer end up unintentionally losing weight due to low appetite, nausea, diarrhea, vomiting, dehydration and increased calorie needs. This can lead ...
Topiramate can cause birth defects including cleft lip and palate. [12] Risk/benefit should be carefully discussed with the full treatment team. Topiramate is considered "probably compatible" with lactation and is not contraindicated in breastfeeding, though monitoring of the infant for diarrhea or poor weight gain may be considered.
Phentermine and topiramate can cause fetal harm. Data from pregnancy registries and epidemiology studies indicate that a fetus exposed to topiramate in the first trimester of pregnancy has an increased risk of oral clefts (cleft lip with or without cleft palate). [3]
Weight loss drugs have been developed since the early twentieth century, and many have been banned or withdrawn from the market due to adverse effects, including deaths; other drugs proved ineffective. Although many earlier drugs were stimulants such as amphetamines, in the early 2020s, GLP-1 receptor agonists became popular for weight loss.
10. You're taking medications that cause weight gain "Certain medications can induce weight gain or hinder weight loss by altering hormones, changing appetite, or causing water retention," says Costa.
Lung cancer has the highest mortality rate in comparison to other forms of cancer, with the leading cause of development due to smoking. [27] The number of smokers in China is rapidly increasing with tobacco killing approximately 3000 people each day. [27] The diagnosis of lung cancer is most common within the 50–59-year age bracket. [26]